Alpha 2.0
Login Register
» Authors » I Bobolea

I Bobolea

Explore the profile of I Bobolea including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 142
Followers 0
Related Specialties
Allergy & Immunology
General Medicine
Public Health
Top 10 Co-Authors
S Quirce
P Barranco
E Arismendi
A Valero
V Del Pozo
C Picado
J Mullol
J Sastre
D Betancor
X Munoz
Published In
J Investig Allergol Clin Immunol
Allergol Immunopathol (Madr)
Allergy
Clin Exp Allergy
Nutr Hosp
Affiliations
Soon will be listed here.
Recent Articles
1.
Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma
Ojanguren I, Quirce S, Bobolea I, Perez de Llano L, Del Pozo V
J Investig Allergol Clin Immunol . 2024 Nov; 35(1):1-11. PMID: 39607429
Asthma, a prevalent chronic respiratory disease, manifests in heterogeneous phenotypes and endotypes, necessitating bespoke therapeutic approaches. Asthma exacerbations are characterized by worsening of symptoms and decline in lung function and...
2.
Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities
Mascaro-Hereza B, Loli-Ausejo D, Valero A, Arismendi E, Bobolea I
J Investig Allergol Clin Immunol . 2024 Nov; PMID: 39607423
No abstract available.
3.
Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project
Rial M, Betancor D, Canas J, Olaguibel J, Rodrigo-Munoz J, Alvarez-Puebla M, et al.
J Investig Allergol Clin Immunol . 2024 Nov; 35(1):53-55. PMID: 39589454
No abstract available.
4.
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Betancor D, Otal M, Olaguibel J, Rodrigo-Munoz J, Alvarez Puebla M, Arismendi E, et al.
J Investig Allergol Clin Immunol . 2024 Jun; 34(3):192-195. PMID: 38888581
No abstract available.
5.
Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"
Barroso B, Valverde-Monge M, Alobid I, Olaguibel J, Rial M, Quirce S, et al.
J Investig Allergol Clin Immunol . 2023 Dec; 33(6):503-504. PMID: 38095497
No abstract available.
6.
Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World Experience
Loli-Ausejo D, Perdomo G, Mascaro B, Martinez-Olondris P, Sanchez-Fernandez M, Mullol J, et al.
J Investig Allergol Clin Immunol . 2023 Feb; 33(3):209-210. PMID: 36820628
No abstract available.
7.
Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma
Betancor D, Olaguibel J, Rodrigo-Munoz J, Alvarez Puebla M, Arismendi E, Barranco P, et al.
J Investig Allergol Clin Immunol . 2022 Nov; 33(4):294-296. PMID: 36331127
No abstract available.
8.
Weight Loss and Vitamin D Improve Hyporesponsiveness to Corticosteroids in Obese Asthma
Bantula M, Tubita V, Roca-Ferrer J, Mullol J, Valero A, Bobolea I, et al.
J Investig Allergol Clin Immunol . 2022 Sep; 33(6):464-473. PMID: 36098275
Background And Objectives: Obesity negatively impacts on the response of asthma patients to inhaled corticosteroids. The mechanisms underlying this impact are unknown. Objective: To demonstrate that the poor response to...
9.
Eosinophilic Sialodochitis: A Rare Comorbidity of Severe Asthma
Gonzalez O, Picado C, Arismendi E, Alobid I, Ramirez J, Valero A, et al.
J Investig Allergol Clin Immunol . 2022 May; 33(2):139-140. PMID: 35503510
No abstract available.
10.
Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Dominguez-Ortega J, Luna-Porta J, Olaguibel J, Barranco P, Arismendi E, Barroso B, et al.
J Investig Allergol Clin Immunol . 2022 May; 33(4):281-288. PMID: 35503227
Background And Objective: Comorbidities can influence asthma control and promote asthma exacerbations (AEs). However, the impact of multimorbidity in AEs, assessed based on long-term follow-up of patients with asthma of...